In line with these studies, our data suggest that the ratio of peripheral CD8+ to CD4+ T cells and RORγt+CD8+ T cells increased in lupus-prone (Figure 3) and pristane-treated (Supplementary Figure S3) mice. The gene discussed is CD8A; the disease is systemic lupus erythematosus.